Navigation Links
PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
Date:11/10/2008

MONTEREY, Calif., Nov. 10 /PRNewswire/ -- PARI Pharma GmbH has successfully completed Phase I and Phase II clinical trials comparing its proprietary PARI Tobramycin 100 (150mg/1.5mL) formulation delivered via a customized Investigational eFlow Nebulizer System to TOBI (tobramycin 300mg/5mL) delivered with the PARI LC PLUS jet nebulizer. While key deposition and safety thresholds were maintained, the marked difference was a reduction in the average inhalation time to 4 - 4 1/2 minutes for the PARI Tobramycin 100, down from 16 - 17 minutes for the TOBI therapy. PARI Tobramycin 100 is an investigational therapy for cystic fibrosis patients with Pseudomonas aeruginosa infections.

Results for both formulations show no difference in the ratio of peripheral to central lung deposition. Maximum tobramycin serum levels were below recommended safety thresholds for systemic and inhaled tobramycin applications, and both tobramycin sputum concentrations and the adverse reaction rates were similar. It appears that, for a twice-daily treatment with PARI Tobramycin 100 delivered via an Investigational eFlow, approximately 10 hours+ per month of inhalation time can be saved compared to TOBI.

"We believe that advancements in our eFlow Technology platform can provide a significant reduction in treatment time while reducing the amount of drug needed to deliver an effective dose -- a true advancement for patients with CF. The results of our Phase I and Phase II trials are encouraging for both the formulation and the optimized delivery device. Same lung deposition, less drug product, shorter inhalation times, and the chance to improve compliance - these are real life improvements. Focusing on drug formulation and device optimization as one project allows us to make these advancements. Our goal is to reduce the burden of treatment for CF patients," said Dr. Manfred Keller, executive vice president and chief scientific officer at PARI Pharma.

"We were very please
'/>"/>

SOURCE PARI Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswir...t he is on a mission to redefine what it means to ...essional counselor with a specialty in family coun...t Wake Forest University, Gladding says research s...n leads to sadness and even depression during the ...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 /PRNewswire-Firs... announced that it will broadcast Doctor Radio ...ograms , an in-depth special hosted by veteran jou...scom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,,...o Know About Mammograms will air November 21 li...
(Date:11/20/2009)... Long durations of exposure to formaldehyde used ...ted with an increased risk of death from myeloid l... November 20 in the Journal of the National Cance...ss mortality from lymphohematopoietic malignancies... funeral industry workers, all of whom may have wo...
(Date:11/20/2009)... (Seattle, Washington) November 20, 2009Emergency...tes assess an estimated 350,000 cardiac arrests ea...sudden cardiac arrest survive. Better quality car...spital EMS providers may be associated with better...ortium (ROC) is the largest clinical research netw...
(Date:11/20/2009)...1 in 4 thinks it,s as short as 34 weeks, potential... , FRIDAY, Nov. 20 (HealthDay News) -- Re...ies continues to climb in the United States. Now,...re confused about what constitutes a full-term bir...ew mothers surveyed in the study considered a baby...
Breaking Medicine News(10 mins):Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4
... that a commonly available antibiotic can improve ...hma, and may also generate significant health care...merican Journal of Respiratory and Critical Care M...t. , The study was conducted by researchers from ...
...ventable -- were diagnosed this year, American Can...ealthDay News) -- Cancer continues to cut a deadl... Society reporting 12 million new cases of maligna...lion of those cancers and 2.9 million deaths are i...
...nless surgery is the,most significant advancement ...ly adopted by a wide variety of academic and priva...phyX(TM) and EsophyX(TM) procedures already,perfor...rained to perform these Natural Orifice Surgery (N...
...issatisfaction with Treatment Experience, ... -, SAN ANTONIO, Dec. 16 Psychosocial support in...MBC) is as important as the need for,disease- and ...vey of 367 women with advanced breast cancer, whic...
...s from Mayo Clinics site in Jacksonville, Fla., of...have found that women whose tumors do not have est...rall outcomes. Because of this, these patients sho...an Antonio Breast Cancer Symposium. , Those cance...
...eliminating pain to,improving an animal,s overall ... attention these days., Gone is the time when vet...al cleaning or pulling of the teeth, according to ...y education,veterinary dentistry has evolved into ...
Other Medicine News:Health News:Antibiotic treatment targets difficult asthma 2Health News:Cancer Killed Almost 8 Million Worldwide in 2007 2Health News:Cancer Killed Almost 8 Million Worldwide in 2007 3Health News:Cancer Killed Almost 8 Million Worldwide in 2007 4Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 2Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 3Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 4Health News:New Survey Underscores Importance of Psychosocial and Educational Needs Among Women with Advanced Breast Cancer 2Health News:New Survey Underscores Importance of Psychosocial and Educational Needs Among Women with Advanced Breast Cancer 3Health News:Survival shortened when ER/PR negative breast cancer spreads to the brain 2Health News:Survival shortened when ER/PR negative breast cancer spreads to the brain 3Health News:Veterinary Dentistry Opens Wide 2
(Date:11/20/2009)... ,, Reportlinker.com announces ...its catalogue. ,, India Medical Equipment Mark...www.reportlinker.com/p0164658/India-Medical-Equipm..._source=prnewswire&utm_medium=pr&utm_campa...edical Equipment Market Analysis and Forecasts to ...
(Date:11/20/2009)... Reportlinker.com announces that a ...alogue. ,, Global Markets for Assisted Reprodu...r.com/p0164742/Global-Markets-for-Assisted-Reprodu...utm_medium=pr&utm_campaign=prnewswire ,, ...e U.S., 15 Countries in Europe and Japan. This rep...
(Date:11/20/2009)...DON, Nov. 20 Boston Scie...that it has received 510(k) clearance from the U.S...pproval to market its WallFlex® Fully Covered...sophageal strictures (obstructions) caused by tumo...sophageal cancer. ,, (Photo: http://www.news...
Breaking Medicine Technology:Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 1Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 2Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 3Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 4Reportlinker Adds Nanoporous Materials Report 13904 1Reportlinker Adds Nanoporous Materials Report 13904 2Reportlinker Adds Nanoporous Materials Report 13904 3Reportlinker Adds Nanoporous Materials Report 13904 4Reportlinker Adds Nanoporous Materials Report 13904 5Reportlinker Adds Nanoporous Materials Report 13904 6Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 1Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 2Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 3Cochlear Americas Announces FDA Approval of the Nucleus 28R 29 5 System the Newest and Most Advanced Cochlear Implant System 56401 4
i-stethos
...hoscope Model 2000 is an ergonomically designed in...nd amplification fourteen times greater than the b...o-use electronic stethoscope is an exceptional too...cs and enhanced clarity make normal and difficult ...
...timulator is a portable, battery-powered bone grow...spinal fusion. The device is worn for 30 minutes e...t to the fusion site. The device uses a unique tec...y low energy signal that is very potent in its abi...
Frontier® CRT-P Biventricular Stimulation Device
Medicine Products: